152 related articles for article (PubMed ID: 17390625)
1. The role of microsphere fabrication methods on the stability and release kinetics of ovalbumin encapsulated in polyanhydride microspheres.
Determan AS; Graham JR; Pfeiffer KA; Narasimhan B
J Microencapsul; 2006 Dec; 23(8):832-43. PubMed ID: 17390625
[TBL] [Abstract][Full Text] [Related]
2. Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres.
Lopac SK; Torres MP; Wilson-Welder JH; Wannemuehler MJ; Narasimhan B
J Biomed Mater Res B Appl Biomater; 2009 Nov; 91(2):938-947. PubMed ID: 19642209
[TBL] [Abstract][Full Text] [Related]
3. Encapsulation, stabilization, and release of BSA-FITC from polyanhydride microspheres.
Determan AS; Trewyn BG; Lin VS; Nilsen-Hamilton M; Narasimhan B
J Control Release; 2004 Nov; 100(1):97-109. PubMed ID: 15491814
[TBL] [Abstract][Full Text] [Related]
4. Amphiphilic polyanhydrides for protein stabilization and release.
Torres MP; Determan AS; Anderson GL; Mallapragada SK; Narasimhan B
Biomaterials; 2007 Jan; 28(1):108-16. PubMed ID: 16965812
[TBL] [Abstract][Full Text] [Related]
5. Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery.
Kipper MJ; Shen E; Determan A; Narasimhan B
Biomaterials; 2002 Nov; 23(22):4405-12. PubMed ID: 12219831
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of polyanhydride microspheres for basal insulin delivery: Effect of copolymer composition and zinc salt on encapsulation, in vitro release, stability, in vivo absorption and bioactivity in diabetic rats.
Manoharan C; Singh J
J Pharm Sci; 2009 Nov; 98(11):4237-50. PubMed ID: 19472196
[TBL] [Abstract][Full Text] [Related]
7. Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis antigens.
Carrillo-Conde B; Schiltz E; Yu J; Chris Minion F; Phillips GJ; Wannemuehler MJ; Narasimhan B
Acta Biomater; 2010 Aug; 6(8):3110-9. PubMed ID: 20123135
[TBL] [Abstract][Full Text] [Related]
8. Protein adsorption on biodegradable polyanhydride microparticles.
Carrillo-Conde B; Garza A; Anderegg J; Narasimhan B
J Biomed Mater Res A; 2010 Oct; 95(1):40-8. PubMed ID: 20740599
[TBL] [Abstract][Full Text] [Related]
9. Controlled delivery systems for proteins using polyanhydride microspheres.
Tabata Y; Gutta S; Langer R
Pharm Res; 1993 Apr; 10(4):487-96. PubMed ID: 8483830
[TBL] [Abstract][Full Text] [Related]
10. The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.
Wafa EI; Geary SM; Goodman JT; Narasimhan B; Salem AK
Acta Biomater; 2017 Mar; 50():417-427. PubMed ID: 28063991
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of protein-loaded polyanhydride microspheres.
Sun L; Zhou S; Wang W; Su Q; Li X; Weng J
J Mater Sci Mater Med; 2009 Oct; 20(10):2035-42. PubMed ID: 19424777
[TBL] [Abstract][Full Text] [Related]
12. Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method.
Uchida T; Yagi A; Oda Y; Goto S
J Microencapsul; 1996; 13(5):509-18. PubMed ID: 8864988
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic relationships between polymer microstructure and drug release kinetics in bioerodible polyanhydrides.
Shen E; Kipper MJ; Dziadul B; Lim MK; Narasimhan B
J Control Release; 2002 Jul; 82(1):115-25. PubMed ID: 12106982
[TBL] [Abstract][Full Text] [Related]
14. Polymer chemistry influences monocytic uptake of polyanhydride nanospheres.
Ulery BD; Phanse Y; Sinha A; Wannemuehler MJ; Narasimhan B; Bellaire BH
Pharm Res; 2009 Mar; 26(3):683-90. PubMed ID: 18987960
[TBL] [Abstract][Full Text] [Related]
15. Polyanhydride microspheres that display near-constant release of water-soluble model drug compounds.
Tabata Y; Langer R
Pharm Res; 1993 Mar; 10(3):391-9. PubMed ID: 8464812
[TBL] [Abstract][Full Text] [Related]
16. Effects of salt addition on the microencapsulation of proteins using W/O/W double emulsion technique.
Pistel KF; Kissel T
J Microencapsul; 2000; 17(4):467-83. PubMed ID: 10898087
[TBL] [Abstract][Full Text] [Related]
17. Protein stability in the presence of polymer degradation products: consequences for controlled release formulations.
Determan AS; Wilson JH; Kipper MJ; Wannemuehler MJ; Narasimhan B
Biomaterials; 2006 Jun; 27(17):3312-20. PubMed ID: 16504288
[TBL] [Abstract][Full Text] [Related]
18. Combinatorial/high throughput methods for the determination of polyanhydride phase behavior.
Thorstenson JB; Petersen LK; Narasimhan B
J Comb Chem; 2009; 11(5):820-8. PubMed ID: 19691268
[TBL] [Abstract][Full Text] [Related]
19. Lipocalin-2-loaded amphiphilic polyanhydride microparticles accelerate cell migration.
Petersen LK; Determan AS; Westgate C; Bendickson L; Nilsen-Hamilton M; Narasimhan B
J Biomater Sci Polym Ed; 2011; 22(9):1237-52. PubMed ID: 20615357
[TBL] [Abstract][Full Text] [Related]
20. Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation.
Uchida T; Goto S; Foster TP
J Pharm Pharmacol; 1995 Jul; 47(7):556-60. PubMed ID: 8568620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
